Ray Blanchard
Clinical sexologist and research psychologist
Ray Blanchard spent fifteen years inside a gender identity clinic before publishing research that would reshape — and inflame — the field. His theory of autogynephilia remains one of the most contested concepts in gender medicine. In conversation with the Beyond Gender hosts, he finally gets to explain what the science actually says, in his own words.
Ray Blanchard built his career at the Clarke Institute of Psychiatry in Toronto — later reorganised as the Centre for Addiction and Mental Health (CAMH) — where he led the gender identity clinic for fifteen years. Working directly with patients seeking sex reassignment, he accumulated the clinical observations that would become his most consequential and most disputed contribution to the field.
That contribution is the theory of autogynephilia: the hypothesis that a distinct category of male-to-female transsexualism is motivated, at least in part, by a man's sexual arousal at the thought or image of himself as a woman. His broader typology separates this group from homosexual transsexuals — those attracted to men — who, he argues, follow an altogether different developmental pathway. The distinction carries real implications for clinical practice, for how gender dysphoria is understood, and for the political narratives that have calcified around transgender identity in public life.
For much of the past two decades, organised activists worked to suppress Blanchard's framework — targeting researchers and publishers associated with it and pushing for its removal from mainstream clinical discourse. That campaign is now extensively documented, and yet his research has never been formally refuted. He served on the Sexual and Gender Identity Disorders Work Group for DSM-5, helping to shape diagnostic criteria even as the underlying theory remained fiercely contested in the culture around it.
In Autogynephilia: The Study Activists Wanted Buried (episode 41), Blanchard joins Stella O'Malley, Mia Hughes, and Dr Bret Alderman for a rare, unhurried conversation — setting out the theory on its own terms, addressing the most persistent objections, and reflecting on what fifteen years of direct clinical work taught him about the patients at the centre of this debate.
